GlassScriptPhysician profile
Hao Zhang
NPI 1346637485
$1,647.72
in general payments reported to CMS, 2019-2025
18 companies · $62.43 in 2025
The $62.43 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2020: $98.67 · 2022: $241 · 2023: $204 · 2024: $19.21 · 2025: $62.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $321.02 | 2022-2023 | Gi Genius |
| Abbvie INC. | $236.28 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $230.91 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $125.00 | 2019 | |
| Pfizer INC. | $121.21 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $107.14 | 2022 | |
| Exelixis INC. | $80.81 | 2019 | |
| Gilead Sciences, INC. | $74.36 | 2019 | |
| Janssen Biotech, INC. | $71.45 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $55.49 | 2019 | |
| Dova Pharmaceuticals | $35.32 | 2019 | |
| Beone Medicines USA, INC. | $33.08 | 2025 | Brukinsa |
| Braintree Laboratories, INC. | $32.78 | 2019 | |
| Mallinckrodt Hospital Products INC. | $29.35 | 2025 | Terlivaz |
| Shionogi INC | $28.89 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.25 | 2019-2020 | |
| Lilly USA, LLC | $19.21 | 2024 | Omvoh |
| Celgene Corporation | $17.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hao Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.